Railroad Therapeutics SRL
1.0 FTERailroad Therapeutics reported total assets of 619,622 € at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Jul 2026), with 1 full-time equivalent.
By total assets for 2025, Railroad Therapeutics ranks in the top half of the 993 companies in its sector (NACE 7210) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Railroad Therapeutics shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +1657 % Total assets +127 % Headcount (avg FTE) 0 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Railroad Therapeutics's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Jul 2026
- Year ended 31 Dec 2024filed on 20 Aug 2025
- Year ended 31 Dec 2023filed on 26 Aug 2024
Railroad Therapeutics's financial analysis
- Solvency70.6%sector median: 57.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Railroad Therapeutics
8 active director(s) in the register.
and 2 more
Railroad Therapeutics's shareholders and holdings →Railroad Therapeutics's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0792.976.285
- VAT number
- BE0792976285
- Peppol
- Registered · 0208:0792976285 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 27 Oct 2022
- Registered office
- 6041 Charleroi
- Size
- Micro · 1.0 FTE
- Latest accounts
- 2025 · filed on 28 Jul 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Railroad Therapeutics (SRL) has been based in Charleroi since 2022, active in: research and experimental development on biotechnology. For 2025, it reports a net loss of 127,809 € and equity of 437,751 €; its revenue is not published. With 1.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 70.6%, above the median of its sector (57.9%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Railroad Therapeutics
Companies in the same business, of comparable size and area, outside its group.
- THERAtRAME Research and experimental development on natural sciences and engineering Liège · balance sheet €2.67m
- Human Waves Research and experimental development on natural sciences and engineering Charleroi · balance sheet 171,624 €
- Sticon Research and experimental development on natural sciences and engineering Tielt · balance sheet 507,688 €
- ODIX Research and experimental development on social sciences and humanities Thimister-Clermont · balance sheet 639,567 €
- Spray Ventures Research and experimental development on natural sciences and engineering Deinze · balance sheet 27,331 €
- Bias, Begeleiding in Arbeidsgebonden Stress Research and experimental development on social sciences and humanities As · balance sheet 474,452 €
- Abaxys Therapeutics Research and experimental development on natural sciences and engineering Villers-la-Ville · balance sheet €1.31m
- Groupe de Recherche et d'Intervention en Ressources Humaines Research and experimental development on social sciences and humanities Soumagne · balance sheet 688,588 €
Frequently asked questions about Railroad Therapeutics
What is the revenue of Railroad Therapeutics?
Railroad Therapeutics files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Railroad Therapeutics?
In Belgium, the VAT number is the company number prefixed with BE: BE0792976285 for Railroad Therapeutics, if the company is VAT-registered. Its company number (CBE) is 0792.976.285.
Where is the registered office of Railroad Therapeutics?
According to the CBE register, the registered office of Railroad Therapeutics is in 6041 Charleroi.
What is the equity of Railroad Therapeutics?
At the close of the 2025 financial year, the equity of Railroad Therapeutics amounts to 437,751 €, a solvency of 70.6% of total assets.
How many people work at Railroad Therapeutics?
1.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Railroad Therapeutics?
The register lists 8 active mandates at Railroad Therapeutics. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Railroad Therapeutics within its sector?
By total assets for 2025, Railroad Therapeutics ranks in the top half of the 993 companies in its sector (NACE 7210) in Belgium that filed accounts for that financial year.
The full file of Railroad Therapeutics
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →